BioSpace News Archive

Business

Alcresta Therapeutics Announces Series of Commercial Milestone Achievements for RELiZORB®

Alcresta Therapeutics, Inc. today announced a series of commercial milestone achievements.

April 1, 2022
·
2 min read
Business

NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year ended December 31, 2021.

April 1, 2022
·
7 min read
Pharm Country

Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the company will be presenting at the BIO International Convention taking place June 13 - 16, 2022 in San Diego, California.

April 1, 2022
·
4 min read
Business

McKesson’s Board of Directors Elects W. Roy Dunbar as New Director

McKesson Corporation announced that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022.

April 1, 2022
·
2 min read
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting

Teva to Present New Analyses of AJOVY ® (fremanezumab-vfrm) Injection and AUSTEDO ® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting.

April 1, 2022
·
13 min read
Business

Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial results on Wednesday, April 27, 2022, prior to the market open.

April 1, 2022
·
1 min read
Business

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update

Pressure BioSciences, Inc. today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2021 financial results and to provide a business update.

April 1, 2022
·
2 min read
Genetown

Fulcrum Therapeutics® Announces Multiple Presentations on FSHD at the American Academy of Neurology’s Annual Meeting

Fulcrum Therapeutics, Inc. today announced multiple oral and poster presentations on losmapimod for facioscapulohumeral muscular dystrophy (FSHD) at the American Academy of Neurology’s Annual Meeting, taking place April 2-7 in Seattle, WA.

April 1, 2022
·
7 min read
Drug Development

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting

Longboard Pharmaceuticals, Inc. today announced that single ascending dose and multiple ascending dose data from the Phase 1 study evaluating LP352 in healthy volunteers will be presented at the American Academy of Neurology.

April 1, 2022
·
4 min read
Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022

Fortress Biotech, Inc. today announced a two-day summit hosted by the B. Riley Securities’ Healthcare Equity Research team, that will feature multiple programs from Fortress’ diversified pipeline.

April 1, 2022
·
5 min read